↓ Skip to main content

Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

Overview of attention for article published in New England Journal of Medicine, August 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Citations

dimensions_citation
798 Dimensions

Readers on

mendeley
609 Mendeley
citeulike
2 CiteULike